Efficacy and Safety of Tazarotene 0.045% Lotion in White Adults with Moderate-to-Severe Acne

Main Article Content

James Del Rosso
Linda Stein Gold
Stephen Tyring
William Philip Werschler
Fran Cook-Bolden
George Han
Neal Bhatia
Eric Guenin

Keywords

efficacy, safety, tazarotene, acne

Abstract

N/A

References

1. Skroza N, et al. J Clin Aesthet Dermatol. 2018;11(1):21-25.

2. Rendon MI, et al. Clin Cosmet Investig Dermatol. 2015;8:231-238.

3. Perkins AC, et al. J Eur Acad Dermatol Venereol. 2011;25(9):1054-1060.

4. Callender VD, et al. J Clin Aesthet Dermatol. 2014;7(7):19-31.

5. Leyden J, et al. Dermatol Ther (Heidelb). 2017;7(3):293-304.

6. Tanghetti EA, et al. J Drugs Dermatol. 2020;19(3):272-279.

7. Bhatia N, et al. J Drugs Dermatol. 2020;19(7):727-734.

8. Martin AR, et al. Clin Exp Dermatol. 2001;26(5):380-385.

Most read articles by the same author(s)

<< < 3 4 5 6 7 8 9 10 > >>